QLS1410

· Qilu Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for QLS1410, covering 2025-09-03 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of QLS1410 in the Treatment of Primary Aldosteronism. [Phase 2]